The Mutaflor® – Escherichia coli (Nissle 1917), serotype O6:K5:H1 – the best researched probiotic available
Authors:
M. Lukáš
Authors place of work:
Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F. a. s., Praha
Published in the journal:
Gastroent Hepatol 2016; 70(3): 281-282
Category:
Drug Profile
doi:
https://doi.org/10.14735/amgh2016281
Zdroje
1. Nissle A. Über die Grundlagen einer neuen ursachlichen Bekampfung der pathologischen Darmflora. Dtsch Med Wochenschr 1916; 42: 1181– 1184.
2. Kruis W, Frič P, Pokrotniekes J et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53(11): 1617– 1623.
3. Matthes H, Krummenerl T, Giensch M et al. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement and Altern Med 2010; 10: 13. doi: 10.1186/ 1472-6882-10-13.
4. Cukrowska B, Lodlnová-Zadnikova R, Enders C et al. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol 2002; 55(2): 204– 209.
Štítky
Paediatric gastroenterology Gastroenterology and hepatology SurgeryČlánok vyšiel v časopise
Gastroenterology and Hepatology
2016 Číslo 3
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Najčítanejšie v tomto čísle
- Colon stenosis of unexplained etiology
- Endoscopic management of sigmoid volvulus
- The Mutaflor® – Escherichia coli (Nissle 1917), serotype O6:K5:H1 – the best researched probiotic available
- Neuroendocrine neoplasms in gastroenterologist practice